These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 37410852)

  • 41. Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study.
    Greven WL; Beulens JW; Biesma DH; Faiz S; de Valk HW
    Diabetes Technol Ther; 2010 Sep; 12(9):695-9. PubMed ID: 20687867
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Examining the Effects of Mindful Eating Training on Adherence to a Carbohydrate-Restricted Diet in Patients With Type 2 Diabetes (the DELISH Study): Protocol for a Randomized Controlled Trial.
    Mason AE; Saslow L; Moran PJ; Kim S; Wali PK; Abousleiman H; Hartman A; Richler R; Schleicher S; Hartogensis W; Epel ES; Hecht F
    JMIR Res Protoc; 2019 Feb; 8(2):e11002. PubMed ID: 30545813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circadian rest-activity rhythms during benzodiazepine tapering covered by melatonin versus placebo add-on: data derived from a randomized clinical trial.
    Baandrup L; Fasmer OB; Glenthøj BY; Jennum PJ
    BMC Psychiatry; 2016 Oct; 16(1):348. PubMed ID: 27737649
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sleep optimization to improve glycemic control in adults with type 1 diabetes: study protocol for a randomized controlled parallel intervention trial.
    Martyn-Nemeth P; Duffecy J; Quinn L; Reutrakul S; Steffen AD; Burke L; Clark Withington MH; Irsheed GA; Perez R; Park M; Saleh A; Mihailescu D; Baron KG
    Trials; 2022 Aug; 23(1):686. PubMed ID: 35986415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A multimeal paradigm producing a low glycemic response is associated with modest cognitive benefits relative to a high glycemic response: a randomized, crossover trial in patients with type 2 diabetes.
    Grout M; Lovegrove JA; Lamport DJ
    Am J Clin Nutr; 2023 May; 117(5):859-869. PubMed ID: 36841444
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Double-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial to Evaluate the Efficacy and Safety of treating Healthcare Professionals with the Adsorbed COVID-19 (Inactivated) Vaccine Manufactured by Sinovac - PROFISCOV: A structured summary of a study protocol for a randomised controlled trial.
    Palacios R; Patiño EG; de Oliveira Piorelli R; Conde MTRP; Batista AP; Zeng G; Xin Q; Kallas EG; Flores J; Ockenhouse CF; Gast C
    Trials; 2020 Oct; 21(1):853. PubMed ID: 33059771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Impact of Physical Activity on Glycemic Variability Assessed by Continuous Glucose Monitoring in Patients With Type 2 Diabetes Mellitus: A Systematic Review.
    Bennetsen SL; Feineis CS; Legaard GE; Lyngbæk MPP; Karstoft K; Ried-Larsen M
    Front Endocrinol (Lausanne); 2020; 11():486. PubMed ID: 32903679
    [No Abstract]   [Full Text] [Related]  

  • 48. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass on glycemic control and remission of type 2 diabetes mellitus: study protocol for a multi-center randomized controlled trial (the DIABAR-trial).
    van Rijswijk A; van Olst N; Meijnikman AS; Acherman YIZ; Bruin SC; van de Laar AW; van Olden CC; Aydin O; Borger H; Beuers UHW; Herrema H; Verheij J; Apers JA; Bäckhed F; Gerdes VEA; Nieuwdorp M; de Brauw LM
    Trials; 2022 Oct; 23(1):900. PubMed ID: 36273149
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of personalized diets by prediction of glycemic responses on glycemic control and metabolic health in newly diagnosed T2DM: a randomized dietary intervention pilot trial.
    Rein M; Ben-Yacov O; Godneva A; Shilo S; Zmora N; Kolobkov D; Cohen-Dolev N; Wolf BC; Kosower N; Lotan-Pompan M; Weinberger A; Halpern Z; Zelber-Sagi S; Elinav E; Segal E
    BMC Med; 2022 Feb; 20(1):56. PubMed ID: 35135549
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficacy and safety of a herbal drug of Coccinia grandis (Linn.) Voigt in patients with type 2 diabetes mellitus: A double blind randomized placebo controlled clinical trial.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    Phytomedicine; 2021 Jan; 81():153431. PubMed ID: 33352495
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Associations between nocturnal urinary 6-sulfatoxymelatonin, obstructive sleep apnea severity and glycemic control in type 2 diabetes.
    Reutrakul S; Siwasaranond N; Nimitphong H; Saetung S; Chirakalwasan N; Chailurkit LO; Srijaruskul K; Ongphiphadhanakul B; Thakkinstian A
    Chronobiol Int; 2017; 34(3):382-392. PubMed ID: 28128991
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Efficacy of Ibuprofen Gargle for Postoperative Pain After Mandibular Third Molar Extraction: Protocol for a Phase II, Placebo-Controlled, Double-Blind, Randomized Crossover Trial.
    Kakei Y; Ioroi T; Ito T; Okazaki Y; Hasegawa T; Yano I; Akashi M
    JMIR Res Protoc; 2022 May; 11(5):e35533. PubMed ID: 35459640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ChemoPROphyLaxIs with hydroxychloroquine For covId-19 infeCtious disease (PROLIFIC) to prevent covid-19 infection in frontline healthcare workers: A structured summary of a study protocol for a randomised controlled trial.
    McEniery CM; Fisk M; Miles K; Kaloyirou F; Hubsch A; Smith J; Wilkinson IB; Cheriyan J
    Trials; 2020 Jul; 21(1):604. PubMed ID: 32616067
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Does supplementation with carnosine improve cardiometabolic health and cognitive function in patients with pre-diabetes and type 2 diabetes? study protocol for a randomised, double-blind, placebo-controlled trial.
    Baye E; Menon K; de Courten MP; Earnest A; Cameron J; de Courten B
    BMJ Open; 2017 Sep; 7(9):e017691. PubMed ID: 28864708
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neu-P11 - a novel melatonin receptor agonist, could improve the features of type-2 diabetes mellitus in rats.
    Li X; He J; Li X; Li Y; Zhou Y; Cai S
    Endokrynol Pol; 2021; 72(6):634-642. PubMed ID: 34647606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of oral melatonin on critically ill adult patients with ICU sleep deprivation: study protocol for a randomized controlled trial.
    Huang H; Jiang L; Shen L; Zhang G; Zhu B; Cheng J; Xi X
    Trials; 2014 Aug; 15():327. PubMed ID: 25135124
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sleep disruption in tetraplegia: a randomised, double-blind, placebo-controlled crossover trial of 3 mg melatonin.
    Spong J; Kennedy GA; Tseng J; Brown DJ; Armstrong S; Berlowitz DJ
    Spinal Cord; 2014 Aug; 52(8):629-34. PubMed ID: 24891007
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study.
    Garfinkel D; Zorin M; Wainstein J; Matas Z; Laudon M; Zisapel N
    Diabetes Metab Syndr Obes; 2011; 4():307-13. PubMed ID: 21887103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.